OBELIX is an abbreviation for “OBesogenic Endocrine disrupting chemicals: LInking prenatal eXposure to the development of obesity later in life.” This European Commission-funded project will run from May 1, 2009 to November 30, 2013. The OBELIX project investigates if prenatal exposure to endocrine disrupting compounds in food plays a role in the development of obesity and related disorders later in life. To achieve this, OBELIX uses a multidisciplinary approach that combines epidemiology, neonatology, endocrinology, toxicology, analytical chemistry and risk assessment.
Four years of OBELIX research comes to an exciting end in Brussels
The European Commission funded OBELIX project, coordinated by IVM, came to an exciting end in October at successful workshop in Brussels attended by over 60 stakeholders from academia, policy and industry. Researchers from 7 laboratories throughout Europe determined the exposure of the developing baby to contaminants and researched the link between exposure and health effects later in life.